- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
Bioproduction
19 - 20 October 2011
Europe's Premier Biological Forum for Improving the Biological Production, Quality and Efficiency of Biomanufacturing while Reducing Costs and Development Timelines
70+ Speakers * 55+ Case Studies * 40 Hours of New Science * 11+ Hours of Networking Time * More Interaction * FDA and MHRA Feedback
CUT COSTS: Disposables. Flexible Manufacturing, Supplier Prequalification, Continuous Manufacturing, Eco Assessment
ENSURE PRODUCT QUALITY: Quality by Design, CQAs, CPPs, Design Space, Control Strategies, Process Validation and ICH Q11
INCREASE PRODUCTIVITY: Upstream and Downstream Innovations, New Technologies
FIND NEW OPPORTUNITIES: Biosimilars, Novel Therapies, Analytics, Formulation
Highlights of BioProduction 2011 - Reduce Costs, Improve Productivity, Ensure Quality, Find New Opportunities
- Discover and evaluate new manufacturing technologies for your projects read more
- Find new strategies to optimise your bioprocess and reduce late-stage complications read more
- Meet innovative new companies and hear the latest on exciting new products read more
- Adopt low-cost expression systems read more
- Compare and contrast the FDA and MHRA’s views on Quality by Design read more
- Gain feedback on recent and impending Guidelines read more
- Qualify your vendors and supply chain read more
- Reduce costs by keeping up to speed with the most innovative disposables on the market read more
- Find a strategy for biosimilars read more
70+ Experts Speakers from Industry, Academia and European and US Regulatory Bodies
70+ Experts Speakers from Industry, Academia and European and US Regulatory Bodies
Dr Dorothee Ambrosius
Senior Vice President, Process Science
Boehringer Ingelheim, Germany
|
Dr Mark Uden
Head of Biopharm Process Research
GSK, UK
|
Dr Paul Varley
VP, Biopharmaceutical Development
MedImmune, UK
|
Dr Ellen McCormick
Senior Director, Bio-Manufacturing Sciences
Pfizer, USA
|
Dr Jean-Marc Cappia
Group VP, Product Management
Sartorius Stedim Biotech, France
|
Patrick van Berkel
VP, Global CMC and R&D
Genmab, The Netherlands
|
Dr Trevor Hallam
Chief Scientific Officer
Sutro Biopharma, USA
|
Dr Mayank Garg
Manager, Manufacturing Sciences
Dr Reddy's, India
|
..
Sponsors
..
..
..
..
Exhibitors - More than 70% of Space Already Taken - Book Now
..
..
..
..
Promotional Participants
..
..
..
..
Media Partners
..
..
..
Key Reasons Why You Simply HAVE to Attend BioProduction
- The most important European Biomanufacturing event this year! - All your peers will be there!
- Our most senior-level speaker line up ever! - 65% of speakers are Director level or above; 33% VPs or SVPs
- The conference of choice for FDA and MHRA regulators - offering advice on implementing QbD
- 12 Brand new sessions on: Biosimilars, novel therapies, new manufacturing technologies, low-cost expression systems, manufacturability, continuous manufacturing, supplier pre-qualification...and many more
- New interactive formats - Expert led panel sessions and On-Stage Interviews with Directors and VPs from GSK, MedImmune and Pfizer
- Out of the box presentation from Simon Weston
Join BioProduction on Twitter
Praise for the 2011 Agenda
"A great opportunity to network with like-minded professionals and to debate some hot topics"
"I particularly like the additional sessions on biosimilars, formulation and novel products"
"The quality of both the presentations and the audience makes Bioproduction a must attend event for Aegis Analytical"
Over 300 Bioprofessionals Attended in 2010
3P Biopharmaceuticals SL
Abbott
Aegis
Aktehom
ALK Abello
Amgen
Archivel Farma Sl
Ark Therapeutics
ATMI bvba
Atoll GmbH
Avecia
Avid Bioservices, Inc.
Baxter Innovations GmbH
Bayer
Bayer Healthcare
Bayer Technology Services GmbH
BD Advanced Bioprocessing
BD Biosciences
Becton Dickinson
Biogen Idec
BIOKIT S.A
Biokit SA
BioMarin
Biomedal
BioMerieux
BioPharm Service Ltd
Bio-Technology General
Boehringer Ingelheim
Boehringer-ingelheim
Bristol Myers Squibb
Cellectis BioResearch
Centocor
Centocor inc USA
Chiron Vaccines
CMC Biologics
Doramaxx Consulting
DSM Biologics
Ege University
Elan Pharma
Eli Lilly and Company
EMD
ETH Zurich
F. Hoffmann-La Roche AG
FDA
Ferring Pharmaceuticals A S
Fulcrum Pharma
Fundacion Pablo Cassara
Gambro Dialysatoren GmbH
GE Healthcare
Genentech
Genentech, Inc
Genor BioPharma Co. Ltd., China
Genzyme
Genzyme Flanders BV BA
Glaxosmithkline
GlaxoSmithKline Biologicals
Glenmark Pharmaceuticals SA
Global Pharmaceutical Supply Group
GlycoThera GmbH
Groupe Novasep SAS
Hyde Engineering & Consulting
INTA
Inter-Lab Ltd
Ipsen
Irvine Scientific
JM Separation BV
JSR MICRO
Laboratorios Hipra
Laureate Pharma
Lek d d
Lek farmacevtska družba d.d., Mengeš / Lek Pharmaceuticals d.d., Menges Site
LFB Biotech
Life Technologies
Lonza
M & W Process Industries GmbH
MarkeTech Group
MedImmune
Menarini Biotech Srl
Merck
Merck Kga
Merck Serono
Micromet AG
Millennium Pharmaceuticals
Millipore Corp
MorphoSys AG
MSD
Mubio Products BV
National Institute for Bioprocessing Research & Training (NIBRT)
NNE Pharmaplan A/S
Northeastern University
Novartis
Novasep
NovImmune SA
Novo Nordisk
Novovax
PacificGMP
Pfizer
Pierre Fabre SA
PIERRE GUERIN SAS
Polymun Scientific
Polypeptide Laboratories AB
RecipharmCobra Biologics Ltd
Regeneron Pharmaceuticals
Rentschler Biotechnologie GmbH
RIVM
Roche Diagnostics GmbH
Sandoz
Sanofi Pasteur
Sanofi-Aventis
Sartorius Stedim Biotech GmbH
Schering Plough
Shire Pharmaceuticals
Sicor Biotech
Swedish Orphan Biovitrum AB
Swissmedic
Synthon BV
Technical University of Lisbon
Teva Pharmaceuticals
Toxicon Europe
Trion Pharma GmbH
UCB
Uni Cambridge
University College London,
University Kent
University of Basel
University of Geneva
University of Kent
University of Latvia
University of Sheffield
Vivalis
Waters
Wyeth
Xcellerex Inc
Ymc Europe GmbH
Poll
Is QbD just a current buzz word or a fundamental change in process strategy?
Please select an answer
Alternative language options
Feeds | Like | Share    |
Corporate Sponsors
Associate Sponsors
Programme Partners
